The Hidden Factor That Could Send D-Wave Quantum Inc (QBTS) Stock to New Lows
Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to Hold. BofA Securities also resumed Underperform rating with a price target of $41. Additionally, Berenberg initiated Hold rating on November 19, […]
Moderna Inc (MRNA) Stock: A Deeper Look at Its True Potential
Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to Hold. BofA Securities also resumed Underperform rating with a price target of $41. Additionally, Berenberg initiated Hold rating on November 19, […]
Moderna Inc (MRNA) Stock Rated Neutral by Goldman
Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to Hold. BofA Securities also resumed Underperform rating with a price target of $41. Additionally, Berenberg initiated Hold rating on November 19, […]
Moderna Inc (MRNA) Stock: Understanding Its Underlying Value
Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to Hold. BofA Securities also resumed Underperform rating with a price target of $$41. Additionally, Berenberg initiated Hold rating on November 19, […]
Moderna Inc (MRNA) Stock’s -0.03% Decrease This Year: What’s the Story?
Goldman has recently reduced Moderna Inc (MRNA) stock to Neutral rating, as announced on January 29, 2025, according to Finviz. Earlier, on December 18, 2024, Argus had reduced the stock from a Buy to Hold. BofA Securities also resumed Underperform rating with a price target of $41. Additionally, Berenberg initiated Hold rating on November 19, […]
Moderna Inc (MRNA) Stock: A Deeper Look at Its True Potential
Argus has recently reduced Moderna Inc (MRNA) stock to Hold rating, as announced on December 18, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock to Underperform, setting a price target of $41. Berenberg also initiated Hold rating with a price target of $42. Additionally, HSBC Securities raised Buy […]
Moderna Inc (MRNA) Stock: Beyond the Surface of Its Performance?
Argus has recently reduced Moderna Inc (MRNA) stock to Hold rating, as announced on December 18, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock to Underperform, setting a price target of $41. Berenberg also initiated Hold rating with a price target of $42. Additionally, HSBC Securities raised Buy […]
MRNA Unveiled: The Shocking Truth Behind Moderna Inc’s Latest Stock Movements
Argus has recently reduced Moderna Inc (MRNA) stock to Hold rating, as announced on December 18, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock to Underperform, setting a price target of $41. Berenberg also initiated Hold rating with a price target of $42. Additionally, HSBC Securities raised Buy […]
Moderna Inc (MRNA) Stock: More Strategic Than Meets the Eye
Argus has recently reduced Moderna Inc (MRNA) stock to Hold rating, as announced on December 18, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock to Underperform, setting a price target of $41. Berenberg also initiated Hold rating with a price target of $42. Additionally, HSBC Securities raised Buy […]
Why Did Argus Give Moderna Inc (MRNA) Stock Hold Rating?
Argus has recently reduced Moderna Inc (MRNA) stock to Hold rating, as announced on December 18, 2024, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock to Underperform, setting a price target of $41. Berenberg also initiated Hold rating with a price target of $42. Additionally, HSBC Securities raised Buy […]